Business Environment

Minkang was originally founded in Beijing, and is a national high-tech enterprise dedicated to the research, development, production and sales of rapid detection products for chronic diseases using biological sensing technology. In 2013, I was attracted by the excellent business environment of Tianjin Binhai by chance. In 2014, I decided to relocate Minkang from Beijing to Tianjin Binhai New Area. Looking back on the past ten years, because of the excellent business environment and strong support created by the government of Binhai New Area for enterprises, Minkang has become the largest innovative research and development enterprise of blood glucose monitoring products in northern China. Here, I would like to express my sincere gratitude to the leaders at all levels of the New Area and the colleagues of the Chamber of Commerce who support the development of enterprises from other places in Tianjin! In recent years, Tianjin has successively issued a series of preferential policies for enterprises, such as the "Eight Articles of Tianjin", the "19 Articles of Private Economy", which has greatly enhanced the confidence of entrepreneurs in investing in Tianjin, and provided great help to enterprises. We will not leave Tianjin Binhai, and will also help attract more enterprises to develop here. 

Innovation and Development

Since ancient times, Huizhou merchants have created brilliant achievements with their own pioneering and innovative spirit. Today, in the current situation that the national economy has shifted from a stage of rapid growth to a stage of high-quality development, we still adhere to the fine tradition of Huizhou merchants, actively recognize changes and take the initiative to innovate and create. At present, Minkang has formed four leading technical systems of electrochemistry, photochemistry, colloidal gold and immunofluorescence in China, and has obtained more than 50 patents and software copyrights. The whole series of products cover the detection of multiple indicators such as blood glucose, blood lipids, blood ketone, uric acid, glycosylated hemoglobin, and rapidly upgrade according to the development path of blood glucose detection - multiple indicators detection - intelligent detection, to create an ecological closed-loop of chronic disease management from monitoring to data analysis to the implementation of diagnosis and treatment programs. We have always adhered to the corporate vision of "building a comprehensive service for chronic diseases", based on the blood sugar monitoring industry, adhered to the research and development investment of more than ten million yuan per year, and carried out strategic cooperation with well-known domestic universities such as the University of Science and Technology of China, actively promoted the transformation of production, research and research results, and continued to output high-quality chronic disease monitoring products. In 2020, the construction of Anhui Heritage Biotechnology Sensing Technology Industrial Park with a total investment of 1 billion yuan by Minkang was officially started, marking that Minkang officially entered the full-service track of real-time monitoring, data analysis and remote intervention for chronic diseases. After completion, the park will be the largest professional industrial park in China's chronic disease detection technology industry.

As one of the company's important development strategies, closed loop artificial pancreas will provide the ultimate solution for insulin application groups. Since 2020, the R&D team has broken through a series of technical barriers, such as long-acting reaction mold, biocompatibility film, microneedle stability, microneedle printing accuracy and blood glucose numerical algorithm, based on CGMs products. Among them, carbon single atom catalytic technology has reached the international leading level. In the future, we will gradually carry out the research and development of the dressing type insulin pump and control algorithm, which is expected to take the lead in realizing the localization process of the full closed-loop artificial pancreas.

Marketing Concept

For a long time, China's primary medical market has been regarded as a marginalized market. With the implementation of a series of policies such as "strengthen community-level medical services", under the guidance of policies such as hierarchical diagnosis and treatment, medical union, etc., grass-roots medical institutions have been paid more attention to. Minkang's blood glucose monitoring products have the inherent advantages of low price, simple operation, compact and convenient, which fully meet the needs of grass-roots medical institutions for patients' blood glucose management mode. In the future, Minkang will aim at the blank market of hospital surgery and outpatient service. In the medium and long term, the blood glucose management in the hospital may break the departmental barriers, and achieve unified management of multiple departments by virtue of the Internet of Things, the Internet, Cloud Computing, AI and other technologies. Minkang will achieve a breakthrough by virtue of its excellent integrated management and blood glucose management ecological engineering construction capabilities.

Finally, Chairman Gan Jianmin expressed his gratitude to all leaders for their long-term care and support for enterprises in Tianjin. Gan Jianmin said: "Through the big platform of the Chamber of Commerce, we can exchange and talk with the elite entrepreneurs in our hometown, enrich our vision, expand our thinking, and make some efforts to the future development of our own enterprises. As a member of the Chamber of Commerce, I feel honored, but also shoulder heavy responsibilities. Minkang will do its best to contribute to the development and construction of Tianjin and Anhui."